Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT01827709Not ApplicableTerminated

Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma

Role: collaborator

NCT01829646Not ApplicableRecruiting

Prediction of Outcome After Chemoradiotherapy for Head and Neck Cancer Using Functional Imaging and Tumor Biology

Role: collaborator

NCT02050490Completed

Effect of a Symptom Diary on Symptom Care and Symptom Burden in Patients Treated With Chemotherapy: a Before-and-after-study

Role: collaborator

NCT02298972Not ApplicableCompleted

Symptom Support During Chemotherapy: A Mixed Method Study in Adult Patients With Cancer

Role: collaborator

NCT02545725Completed

Quality of Life in Colorectal (ex-)Cancer Patients, Based on the Belgian Cancer Registry.

Role: collaborator

NCT02247583Completed

Investigating Patient Satisfaction With Oral Anti-Cancer Treatment

Role: collaborator

All 6 trials loaded